Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Revitalist Lifestyle
(OTCEM:RVLWF)
Intraday
0
[0.00%]
15 minutes delayed
Get Report
Watch
Perks
Buy
Compare Brokers
0
[0.00%]
Last update: 7:00PM
0
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Revitalist Lifestyle Stock (OTC:RVLWF)
Revitalist Lifestyle Stock (OTC: RVLWF)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, April 17, 2023
Psyched: Clinical-Grade MDMA, LSD For Depression, Partnerships For Delivering Psychedelic Therapies & More
Lara Goldstein
-
Apr 17, 2023, 4:14PM
Friday, April 14, 2023
EXCLUSIVE: Ketamine Therapy Leaders Share Bold Vision For Future At Benzinga's Psychedelics Capital Conference
Lara Goldstein
-
Apr 14, 2023, 11:36AM
Wednesday, April 12, 2023
Are You One Of The Lucky 50,000? New Pact Opens Psychedelic Treatment Floodgates
Lara Goldstein
-
Apr 12, 2023, 4:19PM
Monday, January 30, 2023
Women's Footprint In Psychedelics Is Undeniable, Benzinga's Psychedelics Advisory Council's Six New Trailblazers
Lara Goldstein
-
Jan 30, 2023, 12:50PM
Monday, November 21, 2022
Psyched: Musk's Empathy Tweets, Psychedelics In Congress, Oregon's Opt-Outs, MAPS' MDMA Trial And More
Lara Goldstein
-
Nov 21, 2022, 7:13PM
Tuesday, November 15, 2022
New Collaboration Will Bring Psychedelic Clinics & Retreats With Vertical Offerings To The U.S.
Lara Goldstein
-
Nov 15, 2022, 4:21PM
Friday, November 04, 2022
Psychedelics Company Launches New Supplements Line, Joins Global Wellness Market
Lara Goldstein
-
Nov 4, 2022, 2:25PM
Tuesday, November 01, 2022
Ketamine Therapy: Revitalist's New Financing Option, Irwin Naturals Expands Chain Of Clinics
Lara Goldstein
-
Nov 1, 2022, 2:19PM
Friday, October 28, 2022
What Are The Best Psychedelic-Assisted Therapy Clinics In The World? Here Are 5 To Check Out
Lara Goldstein
-
Oct 28, 2022, 12:23PM
Monday, October 03, 2022
Justice Dept Grants $1M To Non-Profits To Help Stem Teen Mental Health Issues & School Violence
Lara Goldstein
-
Oct 3, 2022, 6:10PM
Tuesday, September 13, 2022
Psychedelics Companies Are Teaming Up To Offer Access Veterans
Lara Goldstein
-
Sep 13, 2022, 8:16PM
Friday, August 19, 2022
There Could Be More Hope For Alcohol Addicts As This Company Enters U.S. Addiction Treatment And Relapse Prevention Market
Ernest Dela Aglanu
-
Sponsored
Tuesday, August 16, 2022
Awakn Enters U.S. Addiction Treatment & Relapse Prevention Market With Ketamine Therapy For Alcohol Use Disorder
Lara Goldstein
-
Aug 16, 2022, 1:23PM
Tuesday, June 28, 2022
10 Psychedelics CEOs To Pay Attention To In 2022
Javier Hasse
-
Jun 28, 2022, 2:51PM
Thursday, June 16, 2022
Ketamine-Clinics Revitalist Raises Nearly $4M In Second Round Of Private Placement
Lara Goldstein
-
Jun 16, 2022, 6:47PM
